source
- Bristol Myers Squibb leads $237 million Series E for Pathos AI and launches Alzheimer's collaborationBristol Myers Squibb (BMS) headed a financing round that raised $237 million for biotech Pathos AI. The Series E funding will support Pathos AI's development of its AI‑driven platform for drug dis…
- EY report says MedTech growth driven by commercial leaders, AI and expanding into new care settingsThe latest EY Pulse of the MedTech Industry report looks at the period from 2025 through the first half of 2026. It finds that innovation has spurred more dealmaking and R&D spending, while artific…